ID   RNF4_RAT                Reviewed;         194 AA.
AC   O88846;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-OCT-2024, entry version 178.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF4 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:18408734};
DE   AltName: Full=RING finger protein 4 {ECO:0000305};
DE   AltName: Full=Small nuclear ring finger protein {ECO:0000303|PubMed:9710597};
DE            Short=Protein SNURF {ECO:0000303|PubMed:9710597};
GN   Name=Rnf4 {ECO:0000303|Ref.2, ECO:0000312|RGD:3583};
GN   Synonyms=Snurf {ECO:0000303|PubMed:9710597};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH
RP   AR AND TBP, AND SUBCELLULAR LOCATION.
RC   TISSUE=Testis;
RX   PubMed=9710597; DOI=10.1128/mcb.18.9.5128;
RA   Moilanen A.-M., Poukka H., Karvonen U., Hakli M., Janne O.A., Palvimo J.J.;
RT   "Identification of a novel RING finger protein as a coregulator in steroid
RT   receptor-mediated gene transcription.";
RL   Mol. Cell. Biol. 18:5128-5139(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Yan W., Hirvonen S.J., Moilanen A.-M., Janne O.A., Palvimo J.J.,
RA   Toppari J.;
RT   "Analysis of androgen receptor coregulator SNURF/RNF4 expression in rat
RT   testis.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF 8-ARG--ARG-11, AND SUBCELLULAR LOCATION.
RX   PubMed=11319220; DOI=10.1074/jbc.m009891200;
RA   Haekli M., Karvonen U., Jaenne O.A., Palvimo J.J.;
RT   "The RING finger protein SNURF is a bifunctional protein possessing DNA
RT   binding activity.";
RL   J. Biol. Chem. 276:23653-23660(2001).
RN   [5]
RP   FUNCTION, AUTOUBIQUITINATION, AND MUTAGENESIS OF CYS-136; CYS-139; CYS-177
RP   AND CYS-180.
RX   PubMed=14987998; DOI=10.1016/s0014-5793(04)00070-5;
RA   Haekli M., Lorick K.L., Weissman A.M., Jaenne O.A., Palvimo J.J.;
RT   "Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase
RT   activity.";
RL   FEBS Lett. 560:56-62(2004).
RN   [6]
RP   FUNCTION, SUMOYLATION, AND INTERACTION WITH PML.
RX   PubMed=15707587; DOI=10.1016/j.yexcr.2004.10.029;
RA   Haekli M., Karvonen U., Jaenne O.A., Palvimo J.J.;
RT   "SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.";
RL   Exp. Cell Res. 304:224-233(2005).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 40-ILE--VAL-43;
RP   50-ILE--ASP-53; 61-VAL--VAL-63 AND 71-VAL--VAL-74.
RX   PubMed=18408734; DOI=10.1038/ncb1716;
RA   Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N.,
RA   Jaffray E.G., Palvimo J.J., Hay R.T.;
RT   "RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-
RT   induced PML degradation.";
RL   Nat. Cell Biol. 10:538-546(2008).
RN   [8]
RP   FUNCTION, INTERACTION WITH SUMOYLATED PML, AND SUBCELLULAR LOCATION.
RX   PubMed=20943951; DOI=10.1091/mbc.e10-05-0449;
RA   Geoffroy M.C., Jaffray E.G., Walker K.J., Hay R.T.;
RT   "Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear
RT   bodies.";
RL   Mol. Biol. Cell 21:4227-4239(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-99, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 124-194 IN COMPLEX WITH ZINC IONS,
RP   DOMAIN, AND SUBUNIT.
RX   PubMed=20681948; DOI=10.1042/bj20100957;
RA   Liew C.W., Sun H., Hunter T., Day C.L.;
RT   "RING domain dimerization is essential for RNF4 function.";
RL   Biochem. J. 431:23-29(2010).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which binds polysumoylated chains
CC       covalently attached to proteins and mediates 'Lys-6'-, 'Lys-11'-, 'Lys-
CC       48'- and 'Lys-63'-linked polyubiquitination of those substrates and
CC       their subsequent targeting to the proteasome for degradation
CC       (PubMed:14987998, PubMed:15707587, PubMed:18408734). Regulates the
CC       degradation of several proteins including PML and the transcriptional
CC       activator PEA3 (PubMed:15707587, PubMed:20943951). Involved in
CC       chromosome alignment and spindle assembly, it regulates the kinetochore
CC       CENPH-CENPI-CENPK complex by targeting polysumoylated CENPI to
CC       proteasomal degradation (By similarity). Regulates the cellular
CC       responses to hypoxia and heat shock through degradation of respectively
CC       EPAS1 and PARP1 (By similarity). Alternatively, it may also bind
CC       DNA/nucleosomes and have a more direct role in the regulation of
CC       transcription for instance enhancing basal transcription and steroid
CC       receptor-mediated transcriptional activation (PubMed:11319220,
CC       PubMed:9710597). Catalyzes ubiquitination of sumoylated PARP1 in
CC       response to PARP1 trapping to chromatin, leading to PARP1 removal from
CC       chromatin by VCP/p97 (By similarity). {ECO:0000250|UniProtKB:P78317,
CC       ECO:0000269|PubMed:11319220, ECO:0000269|PubMed:14987998,
CC       ECO:0000269|PubMed:15707587, ECO:0000269|PubMed:18408734,
CC       ECO:0000269|PubMed:20943951, ECO:0000269|PubMed:9710597}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:18408734};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:18408734}.
CC   -!- SUBUNIT: Homodimer (via RING-type zinc finger domain)
CC       (PubMed:20681948). Interacts with GSC2 (By similarity). Interacts with
CC       AR/the androgen receptor and TBP (PubMed:9710597). Interacts with TCF20
CC       (By similarity). Interacts with PATZ1. Interacts with TRPS1; negatively
CC       regulates TRPS1 transcriptional repressor activity. Interacts with PML
CC       (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4, isoform
CC       PML-5 and isoform PML-6) (PubMed:15707587, PubMed:20943951). Interacts
CC       with PRDM1/Blimp-1 (By similarity). {ECO:0000250|UniProtKB:P78317,
CC       ECO:0000250|UniProtKB:Q9QZS2, ECO:0000269|PubMed:15707587,
CC       ECO:0000269|PubMed:20681948, ECO:0000269|PubMed:20943951,
CC       ECO:0000269|PubMed:9710597}.
CC   -!- INTERACTION:
CC       O88846; O88846: Rnf4; NbExp=4; IntAct=EBI-7258907, EBI-7258907;
CC       O88846; P27695: APEX1; Xeno; NbExp=2; IntAct=EBI-7258907, EBI-1048805;
CC       O88846; P61956: SUMO2; Xeno; NbExp=2; IntAct=EBI-7258907, EBI-473220;
CC       O88846; Q13569: TDG; Xeno; NbExp=2; IntAct=EBI-7258907, EBI-348333;
CC       O88846; P51668: UBE2D1; Xeno; NbExp=4; IntAct=EBI-7258907, EBI-743540;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P78317}. Nucleus
CC       {ECO:0000269|PubMed:11319220, ECO:0000269|PubMed:9710597}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:20943951}. Nucleus, PML body
CC       {ECO:0000269|PubMed:20943951}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in testis.
CC       {ECO:0000269|PubMed:9710597}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for the
CC       ubiquitination of polysumoylated substrates.
CC       {ECO:0000269|PubMed:20681948}.
CC   -!- DOMAIN: The SUMO interaction motifs (SIMs) mediates the binding to
CC       polysumoylated substrate. {ECO:0000269|PubMed:18408734}.
CC   -!- PTM: Sumoylated; conjugated by one or two SUMO1 moieties.
CC       {ECO:0000269|PubMed:15707587}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000269|PubMed:14987998}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF022081; AAC35248.1; -; mRNA.
DR   EMBL; AY050655; AAL06715.1; -; mRNA.
DR   EMBL; BC062024; AAH62024.1; -; mRNA.
DR   RefSeq; NP_062055.1; NM_019182.2.
DR   RefSeq; XP_008768493.1; XM_008770271.2.
DR   RefSeq; XP_008768494.1; XM_008770272.2.
DR   RefSeq; XP_008768495.1; XM_008770273.2.
DR   RefSeq; XP_017454634.1; XM_017599145.1.
DR   RefSeq; XP_017454635.1; XM_017599146.1.
DR   PDB; 3NG2; X-ray; 1.80 A; A/B=124-194.
DR   PDB; 4AP4; X-ray; 2.21 A; A=131-194.
DR   PDB; 5AIT; X-ray; 3.40 A; A=131-194.
DR   PDB; 5AIU; X-ray; 2.21 A; A=131-194.
DR   PDBsum; 3NG2; -.
DR   PDBsum; 4AP4; -.
DR   PDBsum; 5AIT; -.
DR   PDBsum; 5AIU; -.
DR   AlphaFoldDB; O88846; -.
DR   BMRB; O88846; -.
DR   SMR; O88846; -.
DR   BioGRID; 247945; 13.
DR   IntAct; O88846; 12.
DR   MINT; O88846; -.
DR   STRING; 10116.ENSRNOP00000074121; -.
DR   iPTMnet; O88846; -.
DR   PhosphoSitePlus; O88846; -.
DR   PaxDb; 10116-ENSRNOP00000019555; -.
DR   Ensembl; ENSRNOT00000095762.1; ENSRNOP00000096496.1; ENSRNOG00000013930.8.
DR   Ensembl; ENSRNOT00055028879; ENSRNOP00055023237; ENSRNOG00055016978.
DR   Ensembl; ENSRNOT00060028458; ENSRNOP00060022905; ENSRNOG00060016549.
DR   Ensembl; ENSRNOT00065049898; ENSRNOP00065040980; ENSRNOG00065028885.
DR   GeneID; 29274; -.
DR   KEGG; rno:29274; -.
DR   AGR; RGD:3583; -.
DR   CTD; 6047; -.
DR   RGD; 3583; Rnf4.
DR   eggNOG; KOG0320; Eukaryota.
DR   GeneTree; ENSGT00390000010318; -.
DR   HOGENOM; CLU_106856_0_0_1; -.
DR   InParanoid; O88846; -.
DR   OrthoDB; 2919802at2759; -.
DR   PhylomeDB; O88846; -.
DR   TreeFam; TF328387; -.
DR   BRENDA; 2.3.2.27; 5301.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; O88846; -.
DR   PRO; PR:O88846; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000013930; Expressed in testis and 19 other cell types or tissues.
DR   ExpressionAtlas; O88846; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; IPI:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IPI:RGD.
DR   GO; GO:0031491; F:nucleosome binding; IDA:UniProtKB.
DR   GO; GO:0032184; F:SUMO polymer binding; IDA:RGD.
DR   GO; GO:0017025; F:TBP-class protein binding; IDA:RGD.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0071243; P:cellular response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEP:RGD.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IMP:RGD.
DR   GO; GO:0072711; P:cellular response to hydroxyurea; IMP:RGD.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IDA:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0120186; P:negative regulation of protein localization to chromatin; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:RGD.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0090234; P:regulation of kinetochore assembly; ISS:UniProtKB.
DR   GO; GO:0090169; P:regulation of spindle assembly; ISS:UniProtKB.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IDA:UniProtKB.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0044752; P:response to human chorionic gonadotropin; IEP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd16533; RING-HC_RNF4; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR043295; RING-HC_RNF4.
DR   InterPro; IPR047134; RNF4.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR23041:SF78; E3 UBIQUITIN-PROTEIN LIGASE RNF4; 1.
DR   PANTHER; PTHR23041; RING FINGER DOMAIN-CONTAINING; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Cytoplasm; DNA-binding; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..194
FT                   /note="E3 ubiquitin-protein ligase RNF4"
FT                   /id="PRO_0000056045"
FT   ZN_FING         136..181
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..20
FT                   /note="Required for ubiquitination activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZS2"
FT   REGION          6..65
FT                   /note="Mediates interaction with TRPS1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZS2"
FT   MOTIF           40..43
FT                   /note="SUMO interaction motif 1"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           50..53
FT                   /note="SUMO interaction motif 2"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           61..63
FT                   /note="SUMO interaction motif 3"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MOTIF           71..74
FT                   /note="SUMO interaction motif 4"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   COMPBIAS        1..34
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         136
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         139
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         158
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         160
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         163
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         166
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         177
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   BINDING         180
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20681948,
FT                   ECO:0007744|PDB:3NG2"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         8..11
FT                   /note="RKRR->AAAA: Altered DNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:11319220"
FT   MUTAGEN         40..43
FT                   /note="IELV->AEAA: No effect. Loss of binding and
FT                   ubiquitination of poly-SUMO chains; when associated with
FT                   50-A--A-53; 61-A--A-63 and 71-A--A-74."
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MUTAGEN         50..53
FT                   /note="IVDL->AADA: Alters binding to poly-SUMO chains. Loss
FT                   of binding and ubiquitination of poly-SUMO chains; when
FT                   associated with 40-A--A-43; 61-A--A-63 and 71-A--A-74."
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MUTAGEN         61..63
FT                   /note="VVV->AAA: No effect. Loss of binding and
FT                   ubiquitination of poly-SUMO chains; when associated with
FT                   40-A--A-43; 50-A--A-53 and 71-A--A-74."
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MUTAGEN         71..74
FT                   /note="VVIV->AAAA: No effect. Loss of binding and
FT                   ubiquitination of poly-SUMO chains; when associated with
FT                   40-A--A-43; 50-A--A-53 and 61-A--A-63."
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   MUTAGEN         136
FT                   /note="C->S: Loss of ubiquitination activity; when
FT                   associated with S-139."
FT                   /evidence="ECO:0000269|PubMed:14987998"
FT   MUTAGEN         139
FT                   /note="C->S: Loss of ubiquitination activity; when
FT                   associated with S-136."
FT                   /evidence="ECO:0000269|PubMed:14987998"
FT   MUTAGEN         177
FT                   /note="C->S: Loss of ubiquitination activity; when
FT                   associated with S-180."
FT                   /evidence="ECO:0000269|PubMed:14987998"
FT   MUTAGEN         180
FT                   /note="C->S: Loss of ubiquitination activity; when
FT                   associated with S-177."
FT                   /evidence="ECO:0000269|PubMed:14987998"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   HELIX           143..147
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   TURN            148..150
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   HELIX           164..173
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   TURN            178..180
FT                   /evidence="ECO:0007829|PDB:3NG2"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:4AP4"
SQ   SEQUENCE   194 AA;  21897 MW;  40C13970FC11DFF2 CRC64;
     MSTRNPQRKR RGGAVNSRQT QKRTRETTST PEISLEAEPI ELVETVGDEI VDLTCESLEP
     VVVDLTHNDS VVIVEERRRP RRNGRRLRQD HADSCVVSSD DEELSKDKDV YVTTHTPRST
     KDEGTTGLRP SGTVSCPICM DGYSEIVQNG RLIVSTECGH VFCSQCLRDS LKNANTCPTC
     RKKINHKRYH PIYI
//
